Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies

References

• UNAIDSGlobal Report. UNAIDS Report on the Global AIDS EpidemicGenevaUNAIDS2012 Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdfAccessed August 24, 2013
   Google Scholar
• MarrazzoJRamjeeGNairGPre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE ttudy (MTN 003)Presented at: the 20th Conference of Retroviruses and Opportunistic Infections (CROI 2013)March 3–6, 2013Atlanta, GA
   Google Scholar
• van der LindeIHIV/AIDS in South Africa: At last the glass is half fullPresented at: the 6th SA AIDS ConferenceJune 18–21, 2013Durban, South Africa
   Google Scholar
• KarimQAAbdool KarimSSFrohlichJACAPRISA 004 Trial GroupEffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in womenScience Express2010329599611681174
   Google Scholar
• GrantRMLamaJRAndersonPLiPrEx Study TeamPreexposure chemoprophylaxis for HIV prevention in men who have sex with menN Engl J Med2010363272587259921091279
   PubMed Web of Science ®Google Scholar
• DobardCSharmaSMartinADurable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissueJ Virol201286271872522072766
   PubMed Web of Science ®Google Scholar
• BaetenJMDonnellDNdasePPartners PrEP Study TeamAntiretroviral prophylaxis for HIV prevention in heterosexual men and womenN Engl J Med2012367539941022784037
   PubMed Web of Science ®Google Scholar
• DentonPWOthienoFMartinez-TorresFOne percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesJ Virol201185157582759321593172
   PubMed Web of Science ®Google Scholar
• KarimSSKashubaADWernerLKarimQADrug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in womenLancet2011378978727928121763939
   PubMed Web of Science ®Google Scholar
• DaiJYGilbertPBHughesJPBrownEREstimating the efficacy of preexposure prophylaxis for HIV prevention among participants with a threshold level of drug concentrationAm J Epidemiol2013177325626323302152
   PubMed Web of Science ®Google Scholar
• World Health OrganizationUNICEFUNFPAWorld BankMaternal Mortality in 2005GenevaWorld Health Organization2007 Available from: http://whqlibdoc.who.int/publications/2007/9789241596213_eng.pdfAccessed July 15, 2010
   Google Scholar
• SinghSWulfDHussainRBankoleASedghGInstituteGAbortion Worldwide: A Decade of Uneven ProgressNew York, NYGuttmacher Institute2009 Available from: http://www.guttmacher.org/pubs/Abortion-Worldwide.pdfAccessed August 24, 2013
   Google Scholar
• SinghSSedghGHussainRUnintended pregnancy: worldwide levels, trends, and outcomesStud Fam Plann201041424125021465725
   PubMed Web of Science ®Google Scholar
• StuartJESecuraGMZhaoQPittmanMEPeipertJFFactors associated with 12-month discontinuation among contraceptive pill, patch, and ring usersObstet Gynecol20131212 Pt 133033623344283
   PubMed Web of Science ®Google Scholar
• FriendDRDoncelGFCombining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologiesAntiviral Res201088Suppl 1S47S5421109068
   PubMed Web of Science ®Google Scholar
• World Health OrganizationFigure 3-1 Comparing Typical Effectiveness of Contraceptive MethodsGenevaWorld Health Organization2007 Available from: http://www.contraceptivetechnology.org/table.htmlAccessed August 24, 2013
   Google Scholar
• SeidmanDSNon-contraceptive benefits of hormonal contraception: time for renewed awarenessEur J Contracept Reprod Health Care201116640740822066889
   PubMed Web of Science ®Google Scholar
• PadianNSvan der StratenARamjeeGMIRA TeamDiaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialLancet2007370958325126117631387
   PubMed Web of Science ®Google Scholar
• JohnsonTJClarkMRAlbrightTHA 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxisAntimicrob Agents Chemother201256126272628323006751
   PubMed Web of Science ®Google Scholar
• MachtDIOn the absorption of drugs and poisons through the vaginaJ Pharmacol Exp Ther1918107509522
   Google Scholar
• DziukPJCookBPassage of steroids through silicone rubberEndocrinology19667812082115948426
   PubMed Web of Science ®Google Scholar
• MishellDRTalasMParlowAFMoyerDLContraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetateAm J Obstet Gynecol197010711001075443056
   PubMed Web of Science ®Google Scholar
• MishellDRLumkinMEContraceptive effect of varying dosages of progestogen in silastic vaginal ringsFertil Steril1970212991035414562
   PubMed Web of Science ®Google Scholar
• World Health OrganizationTask Force on Long-Acting Systemic Agents for Fertility RegulationIntravaginal and intracervical devices for the delivery of fertility regulating agentsJ Steroid Biochem1979111B461467491617
   PubMedGoogle Scholar
• KoetsawangSJiGKrishnaUMicrodose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility RegulationContraception19904121051242107054
   PubMed Web of Science ®Google Scholar
• KoetsawangSJiGKrishnaUMicrodose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility RegulationContraception19904121251412107055
   PubMed Web of Science ®Google Scholar
• BoundsWSzarewskiALoweDGuillebaudJPreliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ringEur J Obstet Gynecol Reprod Biol19934821231258491331
   PubMed Web of Science ®Google Scholar
• WeisbergEFraserISBakerJA randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ringContraception2000622838911102592
   PubMed Web of Science ®Google Scholar
• MuldersTMDiebenTOBenninkHJOvarian function with a novel combined contraceptive vaginal ringHum Reprod200217102594259912351535
   PubMed Web of Science ®Google Scholar
• BracheVPayánLJFaundesACurrent status of contraceptive vaginal ringsContraception201387326427223040125
   PubMed Web of Science ®Google Scholar
• MalcolmKWoolfsonDRussellJAndrewsCIn vitro release of nonoxynol-9 from silicone matrix intravaginal ringsJ Control Release200391335536412932713
   PubMed Web of Science ®Google Scholar
• Van DammeLRamjeeGAlaryMCOL-1492 Study GroupEffectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialLancet2002360933897197712383665
   PubMed Web of Science ®Google Scholar
• KiserPFJohnsonTJClarkJTState of the art in intravaginal ring technology for topical prophylaxis of HIV infectionAIDS Rev2012141627722297505
   PubMed Web of Science ®Google Scholar
• GuptaKMPearceSMPoursaidAEPolyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1J Pharm Sci200897104228423918338805
   PubMed Web of Science ®Google Scholar
• MalcolmRKWoolfsonADTonerCFMorrowRJMcCullaghSDLong-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal ringsJ Antimicrob Chemother200556595495616155060
   PubMed Web of Science ®Google Scholar
• NelASmytheSYoungKSafety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative womenJ Acquir Immune Defic Syndr200951441642319623693
   PubMed Web of Science ®Google Scholar
• WoolfsonADMalcolmRKMorrowRJTonerCFMcCullaghSDIntravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicideInt J Pharm20063251–2828916884869
   PubMed Web of Science ®Google Scholar
• HendrixCWChenBAGudderaVMTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartmentsPLoS ONE201381e5501323383037
   PubMed Web of Science ®Google Scholar
• ThurmanAKimbleTHallPSchwartzJLArcherDFMedroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokineticsContraception201387673874323265980
   PubMed Web of Science ®Google Scholar
• MishellDRPharmacokinetics of depot medroxyprogesterone acetate contraceptionJ Reprod Med199641Suppl 5S381S390
   Web of Science ®Google Scholar
• van den HeuvelMWvan BragtAJAlnabawyAKKapteinMCComparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptiveContraception200572316817416102549
   PubMed Web of Science ®Google Scholar
• TimmerCJMuldersTMPharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ringClin Pharmacokinet200039323324211020137
   PubMed Web of Science ®Google Scholar
• MagnusdóttirEMBjarnadóttirRIOnundarsonPTThe contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative studyContraception200469646146715157790
   PubMed Web of Science ®Google Scholar
• NahoulKDehenninLJondetMRogerMProfiles of plasma estro-gens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesteroneMaturitas19931631852028515718
   PubMed Web of Science ®Google Scholar
• CoutinhoEMCoutinhoEJGonçalvesMTBarbosaICOvulation suppression in women following vaginal administration of oral contraceptive tabletsFertil Steril19823833803816811333
   PubMed Web of Science ®Google Scholar
• KobayashiKMimuraNFujiiHRole of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetateClin Cancer Res2000683297330310955816
   PubMed Web of Science ®Google Scholar
• TsengAHills-NieminenCDrug interactions between antiretrovirals and hormonal contraceptivesExpert Opin Drug Metab Toxicol20139555957223425052
   PubMed Web of Science ®Google Scholar
• Van DammeLCorneliAAhmedKFEM-PrEP Study GroupPreexposure prophylaxis for HIV infection among African womenN Engl J Med2012367541142222784040
   PubMed Web of Science ®Google Scholar
• RosenbergMJWaughMSLongSUnintended pregnancies and use, misuse and discontinuation of oral contraceptivesJ Reprod Med19954053553607608875
   PubMed Web of Science ®Google Scholar
• BlumenthalPDVoedischAGemzell-DanielssonKStrategies to prevent unintended pregnancy: increasing use of long-acting reversible contraceptionHum Reprod Update201117112113720634208
   PubMed Web of Science ®Google Scholar
• MassaiRQuinterosEReyesMVExtended use of a progesterone-releasing vaginal ring in nursing women: a phase II clinical trialContraception200572535235716246661
   PubMed Web of Science ®Google Scholar
• GilliamMLNeustadtAKozloskiMMistrettaSTilmonSGodfreyEAdherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trialObstet Gynecol2010115350351020177280
   PubMed Web of Science ®Google Scholar
• AlexanderNJBakerEKapteinMKarckUMillerLZampaglioneEWhy consider vaginal drug administration?Fertil Steril200482111215236978
   PubMed Web of Science ®Google Scholar
• RomanoJVarianoBCoplanPSafety and availability of dapivirine (TMC120) delivered from an intravaginal ringAIDS Res Hum Retroviruses200925548348819388819
   PubMed Web of Science ®Google Scholar
• MalcolmRKFetherstonSMMcCoyCFBoydPMajorIVaginal rings for delivery of HIV microbicidesInt J Womens Health2012459560523204872
   PubMedGoogle Scholar
• FetherstonSMBoydPMcCoyCFA silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of actionEur J Pharm Sci201248340641523266465
   PubMed Web of Science ®Google Scholar
• ClarkJTJohnsonTJClarkMRQuantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovirJ Control Release2012163224024822981701
   PubMed Web of Science ®Google Scholar
• SmithJRastogiRTellerRSA tenofovir disoproxil fumarate intravaginal ring completely protects against repeated SHIV vaginal challenge in nonhuman primatesPresented at: the 20th Conference of Retroviruses and Opportunistic Infections (CROI 2013)March 3–6, 2013Atlanta, GA
   Google Scholar
• SahotaJBarnesPMMansfieldEBradleyJLKirkmanRJInitial UK experience of the levonorgestrel-releasing contraceptive intravaginal ringAdv Contracept199915431332411145373
   PubMedGoogle Scholar
• LandgrenBMJohannissonEMasironiBDiczfalusyEPharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rateContraception19822665675856820337
   PubMed Web of Science ®Google Scholar
• LockhatFBEmemboluJEKonjeJCSerum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrelFertil Steril200583239840415705381
   PubMed Web of Science ®Google Scholar
• SeeberBZiehrSCGschlieβerAQuantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine systemContraception201286434534922402256
   PubMed Web of Science ®Google Scholar
• HidalgoMMHidalgo-ReginaCBahamondesMVMonteiroIPettaCABahamondesLSerum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine systemContraception2009801848919501221
   PubMed Web of Science ®Google Scholar
• Bayer HealthcareHighlights of Prescribing Information [Package Insert for Skyla Intrauterine System]Wayne, NJBayer HealthCare Pharmaceuticals2013 Available from: http://labeling.bayerhealthcare.com/html/products/pi/Skyla_PI.pdfAccessed August 24, 2013
   Google Scholar
• NatavioMFTaylorDLewisRATemporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine systemContraception201387442643123121828
   PubMed Web of Science ®Google Scholar
• LähteenmäkiPRauramoIBackmanTThe levonorgestrel intrauterine system in contraceptionSteroids20006510–1169369711108878
   PubMed Web of Science ®Google Scholar
• MunuceMJNascimentoJARosanoGFaundesABahamondesLDoses of levonorgestrel comparable to that delivered by the levonorgestrel-releasing intrauterine system can modify the in vitro expression of zona binding sites of human spermatozoaContraception20067319710116371304
   PubMed Web of Science ®Google Scholar
• MossJAMaloneAMSmithTJSimultaneous delivery of tenofovir and acyclovir via an intravaginal ringAntimicrob Agents Chemother201256287588222123689
   PubMed Web of Science ®Google Scholar
• GunawardanaMMossJASmithTJMicrobial biofilms on the surface of intravaginal rings worn in non-human primatesJ Med Microbiol201160Pt 682883721393449
   PubMed Web of Science ®Google Scholar
• MillerLMacFarlaneSAMateriHLA scanning electron microscopic study of the contraceptive vaginal ringContraception2005711656715639076
   PubMed Web of Science ®Google Scholar
• HazanZZumerisJJacobHEffective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic wavesAntimicrob Agents Chemother200650124144415216940055
   PubMed Web of Science ®Google Scholar
• PruthiVAl-JanabiAPereiraBMCharacterization of biofilm formed on intrauterine devicesIndian J Med Microbiol200321316116517643011
   PubMedGoogle Scholar
• CreininMDMeynLABorgattaLMulticenter comparison of the contraceptive ring and patch: a randomized controlled trialObstet Gynecol20081112 Pt 126727718238962
   PubMed Web of Science ®Google Scholar
• DiebenTORoumenFJApterDEfficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstet Gynecol2002100358559312220783
   PubMed Web of Science ®Google Scholar
• NovákAde la LogeCAbetzLvan der MeulenEAThe combined contraceptive vaginal ring, NuvaRing: an international study of user acceptabilityContraception200367318719412618252
   PubMed Web of Science ®Google Scholar
• OddssonKLeifels-FischerBde MeloNREfficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trialContraception200571317618215722066
   PubMed Web of Science ®Google Scholar
• SivinIMishellDRJrAlvarezFContraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trialContraception200571212212915707562
   PubMed Web of Science ®Google Scholar
• van der StratenAMontgomeryETChengHHigh acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African womenAIDS Behav20121671775178622644068
   PubMed Web of Science ®Google Scholar
• Jung-HoffmanCKuhlHPharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolismAm J Obstet Gynecol19901636 Pt 2218321972147819
   PubMed Web of Science ®Google Scholar
• KoetsawangSJiGKrishnaUMicrodose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility RegulationContraception19904121511672107057
   PubMedGoogle Scholar
• BracheVMishellDRLahteenmakiPOvarian function during use of vaginal rings delivering three different doses of NestoroneContraception200163525726111448466
   PubMed Web of Science ®Google Scholar
• XiaoBLZhangXLFengDDPharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrelContraception19853254554713936678
   PubMed Web of Science ®Google Scholar
• LandgrenBMJohannissonEMasironiBDiczfalusyEPharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 daysContraception1979193253271572278
   PubMed Web of Science ®Google Scholar
• JohannissonEBrosensICornillieFMorphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 daysContraception19914343613741906792
   PubMed Web of Science ®Google Scholar
• Van de PerrePSegondyMFoulongneVHerpes simplex virus and HIV-1: deciphering viral synergyLancet Infect Dis20088849049718652995
   PubMed Web of Science ®Google Scholar
• GreenblattRMLukehartSAPlummerFAGenital ulceration as a risk factor for human immunodeficiency virus infectionAIDS19882147503128996
   PubMed Web of Science ®Google Scholar
• WasserheitJNEpidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseasesSex Transm Dis199219261771595015
   PubMed Web of Science ®Google Scholar
• RoyceRASeñaACatesWCohenMSSexual transmission of HIVN Engl J Med199733615107210789091805
   PubMed Web of Science ®Google Scholar
• ThurmanARDoncelGFHerpes simplex virus and HIV: genital infection synergy and novel approaches to dual preventionInt J STD AIDS201223961361923033511
   PubMed Web of Science ®Google Scholar
• NathASitruk-WareRProgesterone vaginal ring for contraceptive use during lactationContraception201082542843420933116
   PubMed Web of Science ®Google Scholar
• SivinIDíazSCroxattoHBContraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUDContraception19975542252329179454
   PubMed Web of Science ®Google Scholar
• RoumenFJApterDMuldersTMDiebenTOEfficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiolHum Reprod200116346947511228213
   PubMed Web of Science ®Google Scholar
• FraserISLacarraMMishellDRVaginal epithelial surface appearances in women using vaginal rings for contraceptionContraception200061213113810802278
   PubMed Web of Science ®Google Scholar
• FraserISLähteenmäkiPElomaaKVariations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active womenHum Reprod19991481974197810438412
   PubMed Web of Science ®Google Scholar
• MayerKHVenkateshKKAntiretroviral therapy as HIV prevention: status and prospectsAm J Public Health2010100101867187620724682
   PubMed Web of Science ®Google Scholar
• SchwartzJLRountreeWKashubaADMA multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gelPLoS One2011610e2597422039430
   PubMed Web of Science ®Google Scholar
• Abdool KarimSSCAPRISA 004 two years on: Ten key lessons and their implicationsPresented at: Microbicides 2012April 12, 2012Sydney, Australia
   Google Scholar
• MartinHLRichardsonBANyangePMVaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisitionJ Infect Dis199918061863186810558942
   PubMed Web of Science ®Google Scholar
• LagaMManokaAKivuvuMNon-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort studyAIDS199371951028442924
   PubMed Web of Science ®Google Scholar
• MyerLDennyLTelerantRSouzaMDWrightTCJrKuhnLBacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control studyJ Infect Dis200519281372138016170754
   PubMed Web of Science ®Google Scholar
• ValoreEVWileyDJGanzTReversible deficiency of antimicrobial polypeptides in bacterial vaginosisInfect Immun200674105693570216988245
   PubMed Web of Science ®Google Scholar
• DaviesGCFengLXNewtonJRDiebenTOCoelingh-BenninkHJThe effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal floraContraception19924555115181623721
   PubMed Web of Science ®Google Scholar
• De SetaFRestainoSDe SantoDEffects of hormonal contraception on vaginal floraContraception201286552652922520642
   PubMed Web of Science ®Google Scholar
• RavelJGajerPAbdoZVaginal microbiome of reproductive-age womenProc Natl Acad Sci U S A2011108Suppl 1S4680S4687
   PubMed Web of Science ®Google Scholar
• CamachoDPConsolaroMEPatussiEVDonattiLGasparettoASvidzinskiTIVaginal yeast adherence to the combined contraceptive vaginal ring (CCVR)Contraception200776643944318061701
   PubMed Web of Science ®Google Scholar
• UngchusakKRehleTThammapornpilapPSpiegelmanDBrinkmannUSiraprapasiriTDeterminants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal studyJ Acquir Immune Defic Syndr Hum Retrovirol19961255005078757428
   PubMedGoogle Scholar
• MartinHLJrNyangePMRichardsonBAHormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1J Infect Dis19981784105310599806034
   PubMed Web of Science ®Google Scholar
• BaetenJMBenkiSChohanVHormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan womenAIDS200721131771177717690576
   PubMed Web of Science ®Google Scholar
• MorrisonCSChenPLKwokCHormonal contraception and HIV acquisition: reanalysis using marginal structural modelingAIDS201024111778178120588106
   PubMed Web of Science ®Google Scholar
• HeffronRDonnellDReesHPartners in Prevention HSV/HIV Transmission Study TeamUse of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort studyLancet Infect Dis2012121192621975269
   PubMed Web of Science ®Google Scholar
• MarxPASpiraAIGettieAProgesterone implants enhance SIV vaginal transmission and early virus loadNat Med1996210108410898837605
   PubMed Web of Science ®Google Scholar
• SmithSMBaskinGBMarxPAEstrogen protects against vaginal transmission of simian immunodeficiency virusJ Infect Dis2000182370871510950763
   PubMed Web of Science ®Google Scholar
• JiangYTianBAgyMBSaifuddinMTsaiCCMacaca fascicularis are highly susceptible to an RT-SHIV following intravaginal inoculation: a new model for microbicide evaluationJ Med Primatol200938Suppl 1S39S46
   Web of Science ®Google Scholar
• PalRNuttallJGalminLWeissDChungHKRomanoJCharacterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaquesVirology2009386110210819195672
   PubMed Web of Science ®Google Scholar
• SalléBBrochardPBourryOInfection of macaques after vaginal exposure to cell-associated simian immunodeficiency virusJ Infect Dis2010202333734420569157
   PubMed Web of Science ®Google Scholar
• VeazeyRSShattockRJPopeMPrevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120Nat Med20039334334612579198
   PubMed Web of Science ®Google Scholar
• MillerLPattonDLMeierAThwinSSHootonTMEschenbachDADepomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epitheliumObstet Gynecol200096343143910960638
   PubMed Web of Science ®Google Scholar
• BahamondesLTrevisanMAndradeLThe effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-ProveraContraception2000621232711024225
   PubMed Web of Science ®Google Scholar
• MauckCKCallahanMMBakerJThe effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopyContraception1999601152410549448
   PubMed Web of Science ®Google Scholar
• IldgrubenAKSjöbergIMHammarströmMLInfluence of hormonal contraceptives on the immune cells and thickness of human vaginal epitheliumObstet Gynecol2003102357158212962945
   PubMed Web of Science ®Google Scholar
• HaaseATEarly events in sexual transmission of HIV and SIV and opportunities for interventionsAnnu Rev Med20116212713921054171
   PubMed Web of Science ®Google Scholar
• PudneyJQuayleAJAndersonDJImmunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zoneBiol Reprod20057361253126316093359
   PubMed Web of Science ®Google Scholar
• HladikFSakchalathornPBallweberLInitial events in establishing vaginal entry and infection by human immunodeficiency virus type-1Immunity200726225727017306567
   PubMed Web of Science ®Google Scholar
• PattonDLThwinSSMeierAHootonTMStapletonAEEschenbachDAEpithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycleAm J Obstet Gynecol2000183496797311035348
   PubMed Web of Science ®Google Scholar
• WieserFHosmannJTschugguelWCzerwenkaKSedivyRHuberJCProgesterone increases the number of Langerhans cells in human vaginal epitheliumFertil Steril20017561234123511384659
   PubMed Web of Science ®Google Scholar
• WiraCRFaheyJVGhoshMPatelMVHickeyDKOchielDOSex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogensAm J Reprod Immunol201063654456520367623
   PubMed Web of Science ®Google Scholar
• ChandraNThurmanARAndersonSDepot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissuesAIDS Res Hum Retroviruses201329359260123189932
   PubMed Web of Science ®Google Scholar
• NaranbhaiVAbdool KarimSSAltfeldMCAPRISA004 TRAPS teamInnate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gelJ Infect Dis20122067993100122829639
   PubMed Web of Science ®Google Scholar
• RobertsLPassmoreJAMlisanaKGenital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in womenJ Infect Dis2012205219420322190580
   PubMed Web of Science ®Google Scholar
• ClarkMKSowersMLevyBTTenhundfeldPMagnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraceptionFertil Steril200175587187711334896
   PubMed Web of Science ®Google Scholar
• FotherbyKSaxenaBNShrimankerKA preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthateFertil Steril19803421311397409232
   PubMed Web of Science ®Google Scholar
• OrtizAHirolMStanczykFZGoebelsmannUMishellDRSerum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPAJ Clin Endocrinol Metab19774413238833262
   PubMed Web of Science ®Google Scholar
• WisniewskiPMWilkinsonEJPostpartum vaginal atrophyAm J Obstet Gynecol19911654 Pt 2124912541659199
   PubMed Web of Science ®Google Scholar
• NilssonKRisbergBHeimerGThe vaginal epithelium in the postmenopause – cytology, histology and pH as methods of assessmentMaturitas199521151567731384
   PubMed Web of Science ®Google Scholar
• RoySCaillouetteJCRoyTFadenJSVaginal pH is similar to follicle-stimulating hormone for menopause diagnosisAm J Obstet Gynecol200419051272127715167829
   PubMed Web of Science ®Google Scholar
• PetricevicLDomigKJNierscherFJCharacterisation of the oral, vaginal and rectal Lactobacillus flora in healthy pregnant and postmenopausal womenEur J Obstet Gynecol Reprod Biol20121601939922088236
   PubMed Web of Science ®Google Scholar
• PabichWLFihnSDStammWEScholesDBoykoEJGuptaKPrevalence and determinants of vaginal flora alterations in postmenopausal womenJ Infect Dis200318871054105814513427
   PubMed Web of Science ®Google Scholar
• GondoFda SilvaMGPolettiniJVaginal flora alterations and clinical symptoms in low-risk pregnant womenGynecol Obstet Invest201171315816221160139
   PubMed Web of Science ®Google Scholar
• GorodeskiGIEstrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal womenMenopause20071461012101917572644
   PubMed Web of Science ®Google Scholar
• JonesJMosherWDanielsKDivision of vital statisticsCurrent contraceptive use in the United States, 2006–2010 and changes in patterns of use since 1995Natl Health Stat Report201260126 Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr060.pdfAccessed August 24, 2013
   Google Scholar
• un.org [homepage on the Internet]World contraceptive use 2010United Nations, Department of Economic and Social Affairs, Population Division2010 [updated February 2011; cited July 15, 2011]. Available from: http://www.un.org/esa/population/publications/wcu2010/Data/UNPD_WCU_2010_Contraceptive_prevalence_method.xlsAccessed August 24, 2013
   Google Scholar